Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Novartis acquires Vedere Bio to advance optogenetic gene therapy for vision restoration In a significant acquisition that could reshape the landscape of gene therapy for vision restoration, Swiss pharmaceutical giant… bypharmanewsdailyOctober 29, 2020